Posts by Aneesh Bapat, MD
-
SGK1 Is a Potential New Target to Prevent Obesity-related Atrial Fibrillation
Aneesh Bapat, MD, David Milan, MD, Saumya Das, MD, PhD, and colleagues demonstrated in a mouse model that genetic inhibition of serum glucocorticoid kinase 1 (SGK1) prevents some of the atrial fibrillation risk associated with diet-induced obesity, suggesting SGK1 is an attractive potential therapeutic target.
Biography
Aneesh Bapat, MD, is a cardiac electrophysiologist in the Cardiovascular Research Center at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School.